AVL-292 |
AVL-292 : Covalent inhibitor of BTK
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| BTK |
|
|
Covalent Inhibitor
Up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50(app) - BMX 0.7 nM, ITK 36 nM, TEC 6.2 nM, TXK 8.9 nM
Potency Assay Off-Target:
High selectivity was noted against kinases with a comparable Cys (EGFR, ITK, JNK3).
CC-292 was run ...
Potency Cellular
In Vitro
BTK
Mode of Action: Covalent Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1124/jpet.113.203489
In Vivo Validations
Mouse
Dose: 50 mg/kg
Route of delivery:
Oral
Organ of interest (O):
spleen, joint
Target engagement assay:
In the spleen, BTK occupancy was measured.
Reference: --
Chemical Information
| Molecular Formula | C22H22FN5O3 |
| SMILEs | C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1 |
| InChI | InChI=1S/C22H22FN5O3/c1-3-20(29)25-16-5-4-6-17(13-16)26-21-19(23)14-24-22(28-21)27-15-7-9-18(10-8-15)31-12-11-30-2/h3-10,13-14H,1,11-12H2,2H3,(H,25,29)(H2,24,26,27,28) |
| Molecular weight | 423.17 Da |
| AlogP | 0.0 |
| HBond acceptors | 8 |
| HBond donors | 3 |
| Atoms | 53 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.